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Abstract
Previous studies have demonstrated chemo-preventive potential of cruciferous and
apiaceous vegetables against colon cancer. Colon inflammation is one condition closely related
with colon cancer initiation. Therefore, we wanted to compare if total western diet (TWD) was
as pro-inflammatory as died-induced obesity (DIO) and a better dietary model for human
conditions, and determine if diet supplementation with cruciferous (broccoli, watercress and
cabbage) or apiaceous vegetables (celery and parsnip) could reduce dietary inflammation, and
which vegetable was more effective.
Male CBL57/6J mice were fed chow for seven days, on day eight, mice were assigned to
one of the following diets: American Institute of Nutrition, 1993 diet for growth, pregnancy and
lactation (AIN-93G), DIO, DIO+21% cruciferous (DC), DIO+21% apiaceous (DA), TWD,
TWD+21% cruciferous (TC), and TWD+21% apiaceous (TA). On day 84 blood, colon, and liver
were collected and stored at -80°C. Cytokine were measured in plasma (ARY006 array), and
pro-inflammatory related genes were measured in colon tissue (PAMM-011Z array).
The DIO group did not differ in weight gain compared to any other group. Some
cytokines signals in DA were likely to be increased when compared to DIO (G-CSF, IL-5, IL-6 ,
IL-7, I-TAC, TNF-α, TREM-1; p < 0.005) and when compared to DC (G-CSF, IL-2, IL-5, IL-7,
IL-23, IP-10, I-TAC, M-CSF, TARC, TIMP-1, TNF-α; p < 0.005). Bmp2 had a higher mRNA
expression in all diets compared to basal diet AIN-93G; p= 0.001. Ccl1 had similar mRNA
expression in all diets compared to AIN-93G and DIO; p= 0.001. Ccl19 mRNA was equality
expressed in all diets except for DIO; p= 0.000. Ccl4 had a higher mRNA expression in TC diet
only when compare with DIO and DC; p= 0.058.

DIO and TWD did not induce inflammation or obesity. Vegetable-supplemented diets
induced secretion of some pro-inflammatory cytokines. Cruciferous had a smaller inflammatory
response compared to apiaceous vegetables. Although no beneficial effect was seen of
vegetables on inflammatory pathways, we do not negate potential chemo-preventive effects by
other mechanisms.

Colon Cancer, inflammation, cruciferous vegetables and apiaceous vegetables.

Acknowledgments
This work is the result of a team effort, that guided me and supported me through the planning,
execution and conclusion of this project. My sincere gratitude to

My committee members: Dr. Sabrina Trudo, Dr. Jae Kyeom Kim, Dr. Gisela Erf.
The animal facility staff: Tina Poseno, Dr. Kate William, Lane Vassar, Daniel.
The members of Dr. Kim’s Lab and Dr. Zhao’s Lab: Dr. Jeonghoon Pan, Yun Jeong Cho, Jingsi
Tang, Xiaoyuan Wei, Jianmin Chai.

Dedication
To Rosa Elba Morales Obando, an example of a life in service to others.

Table of Contents
Chapter 1: Introduction ............................................................................................................... 1
Chapter 2: Literature Review ...................................................................................................... 4
Colon Cancer Worldwide and in the United States of America ................................................. 4
What is Colon Cancer? ................................................................................................................ 5
Precursor lesions of colorectal carcinoma. .............................................................................. 5
Risk Factors of Colon Cancer ..................................................................................................... 9
Nonmodifiable risk factors. ..................................................................................................... 9
Modifiable risk factors........................................................................................................... 10
Inflammation and Colon Cancer ............................................................................................... 13
Role of inflammation in colon cancer risk. ........................................................................... 13
Proposed Inflammatory pathways. ........................................................................................ 16
Diet and Colon Inflammation as a Risk of Colon Cancer ......................................................... 19
Diet constituents that increase colon cancer risk ................................................................... 19
Diet constituents that decrease colon cancer risk .................................................................. 21
Chapter 3: Materials and Methods ........................................................................................... 23
Animals and experimental design ............................................................................................. 23
Study diets ................................................................................................................................. 24
Plasma cytokine expression assay ............................................................................................. 25
Colon cytokine expression array ............................................................................................... 26
Statistical analysis ..................................................................................................................... 27
Chapter 4: Results....................................................................................................................... 30
Food intake ................................................................................................................................ 30
Body and Tissue weight ............................................................................................................ 30
Plasma cytokine expression assay ............................................................................................. 30
Colon cytokine expression array ............................................................................................... 31
Chapter 5: Discussion and Future Directions .......................................................................... 38
References .................................................................................................................................... 44
Appendix ...................................................................................................................................... 54

1
Chapter 1: Introduction
Colorectal cancer (CRC) is the third most common cancer diagnosed worldwide and the
second leading cause of cancer death in the United States (Thélin & Sikka, 2015). Worldwide
epidemiological studies have documented the highest rates of colorectal cancer in developed
countries with western-style diets, which are diets high in fats, red meats, and refined grains
while low in fiber and fruit consumption (Arnold et al., 2017; Boyle & Langman, 2000).
Furthermore, several studies show that migrants and their children acquired the colorectal cancer
risk of their host countries, demonstrating that colorectal cancer is associated with environmental
factors, diet being part of that environment (Haggar & Boushey, 2009; Santarelli, Pierre, &
Corpet, 2008). Even with advances in the treatment of colorectal cancer, the survival rates
improve too slowly. Therefore, colorectal cancer prevention is a major goal for public health and
the understanding of the mechanism of colorectal cancer prevention would improve prevention
strategies (Santarelli et al., 2008).
The effects of diet in the incidence of colorectal cancer is related to whether the diet is
pro-inflammatory or anti-inflammatory. Several studies proposed possible pathways by which
pro-inflammatory foods, such as high fat foods and red meat, may increase risk, these include the
presence of heme iron and the production of carcinogens such as polycyclic aromatic
hydrocarbons (Santarelli et al., 2008), but there are comparatively fewer studies about antiinflammatory foods and even fewer about possible mechanisms responsible for their antiinflammatory effects. One of these mechanisms include the suppression of NF- κB, (which is a
central mediator of inflammation)n by isothiocyanates present in cruciferous vegetables (Pahl,
1999).

2
This type of vegetable has also been studied for its protective effects against colon cancer
and some mechanisms include: the regulation of epigenetic and the metabolism xenobiotics,
inhibition of cell proliferation and tumorigenesis, and their antioxidant activity (Pan et al., 2018).
Apiaceous vegetables rich in furanocoumarins and polyacetylenes, is another group that has also
shown chemo-preventing effects against colon cancer by the inhibition of cytochrome P450
(Boyle & Langman, 2000; J. Kim, Gallaher, Chen, Yao, & Trudo, 2014; J. Kim et al., 2017;
Peterson, Lampe, Bammler, Gross-Steinmeyer, & Eaton, 2006).
It is important to mention that most studies have been carried out in animal models (rats,
mice), testing individual compounds, but not the use of whole vegetables or a combination of
different classes of vegetables as would be consumed in real life. In addition, these studies have
used a high-fat diet (60% fat) as the background diet of their studies. However, intake of 60% of
calories from fat is extreme and unlikely in real life settings. For these reasons, the aims of our
study were:
1) To compare the intestinal inflammatory response of two background diets, diet
induced obesity (DIO) and total western diet (TWD) in C57BL/6J mice, and identify which one
of these rodent diets would serve as a better dietary model of inflammation that reflects the
human condition;
2) To determine if supplementation with two classes of vegetables, cruciferous (broccoli,
cabbage, and watercress) and apiaceous (celery, and parsnips), can reduce the inflammatory
response to an inflammation-producing diet, and which class of vegetable is more effective.

3
We hypothesized that TWD would be as pro-inflammatory as DIO, and therefore a better
dietary model of inflammation that reflects the human condition. Furthermore, we also expected
that vegetable supplementation would reduce the inflammatory response produced by diet,
through the modulation of keys signaling pathways such as: NF-κB, Wnt/β catenin, or MAPK.
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Chapter 2: Literature Review
Colon Cancer Worldwide and in the United States of America
Colorectal cancer continues to be the third most common cancer worldwide and the
fourth most common cause of cancer death with nearly 1.4 million new cases and 700,000 deaths
reported in 2012. It is predicted that the worldwide incidence of colorectal cancer will increase to
2.4 million by 2035. About two thirds of colorectal cancer cases in 2012 occurred in countries
with high or very high development indices (World Cancer Research Fund/American Institute
for Cancer Research, 2017).
In terms of geographical distribution, the Human Development Index (HDI) helps to
compare the trends in incidence and mortality rates between developed and developing countries.
There is an increasing incidence and mortality in countries with medium to high HDI, in
particular Eastern Europe, Asia, and South America. Stabilizing or decreasing mortality trends
are only observed in highly developed countries like USA, Australia, New Zealand, and several
Western European countries. Females tend to have lower incidence rates than males, maintaining
this pattern across the globe (Arnold et al., 2017).
In the United States, colorectal cancer is the third most common cancer and the second
leading cause of death. In 2018, it was estimated to have caused 140,250 new cases representing
8.1% of all new cancer cases. From these, 97,220 cases corresponded to colon cancer and 43,030
to rectal cancer. As for mortality colorectal cancer, it is estimated to cause 50,630 deaths
representing 8.3% of all cancer deaths in 2018. Colorectal cancer is more common in men than
women and among those of African American descent (Noone AM, 2018).
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What is Colon Cancer?
The National Cancer Institute Dictionary defines cancer as the term for diseases in which
abnormal cells divide without control and can invade nearby tissues. These cells can also spread
to other parts of the body through the blood and lymph systems. Colon cancer is a cancer that
forms in the tissues of the colon. Rectal cancer and colon cancer are generally grouped together
because of their many common features. In this case, the term colorectal cancer is used to refer
to the cancer that starts in the colon or the rectum (American Cancer Society, 2017).
Precursor lesions of colorectal carcinoma.
There are many types of colorectal cancer, but around 96% of colorectal cancers are
classified as adenocarcinomas. Some other less common types of colorectal cancer are: carcinoid
tumors that start in hormone-making cells in the intestine; gastrointestinal stromal tumors that
start in the interstitial cells of Cajal, and lymphomas that start in the lymph nodes, but can also
start in the digestive system (for example, Non-Hodgkin Lymphoma). In addition, sarcomas,
which are very rare, can be initiated in blood vessels, muscle, or connective tissues in the walls
of the colon and the rectum (American Cancer Society, 2017). Since the majority of colorectal
cancers are adenocarcinomas, we will focus on this type of cancer and its classification in this
review.

Adenocarcinomas.
Adenocarcinomas start in the glandular epithelial tissues of the colon and the rectum.
Polyps are the most common precursor lesion of this type of cancer. According to their shape,
lesions can also be classified as (a) pedunculated, if it has a mushroom-like shape; (b) sessile, if
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it is elevated but completely attached to the colon wall; (c) flat, if it is elevated less than half of
the diameter of the lesion; and (d) depressed, if part of the lesion surface is below the level of the
surrounding mucosa. Furthermore, precursor lesions can also include syndromes such as
inflammatory bowel disease and hamartomatous polyposis syndromes. Colorectal epithelial
polyps have a complex classification and are a broad group of dysplastic and nondysplastic
neoplasms, many of which are widely recognized to confer risk of colorectal carcinoma.

Nondysplastic serrated polyps.

This type of polyp is divided in two groups (a) sessile serrated polyps with proliferative
abnormalities and (b) hyperplastic polyps without proliferative abnormalities (American Cancer
Society, 2017). The latter are the most common type of polyps in the colorectum. They are pale,
sessile polyps with smooth contours and may display a layer of mucus on the surface (Waye JD,
1990). Occasionally, cells are multinucleated and likely to represent a degenerative phenomenon
(Kambham, Troxell, & Longacre, 2005). Mutually exclusive KRAS and BRAF mutations (genes
coding for proteins involved in cell signaling and that play an important role in the
transformation of small to intermediate sized adenomas) are frequently present in hyperplastic
polyps, therefore challenging the notion that they are nonneoplastic lesions and lack malignant
potential. KRAS mutations are detected in up to 47% of hyperplastic polys while BRAF
mutations are detected in 40% to 76% (O'Brien et al., 2006). The other type of nondysplastic
polyps are sessile serrated polyps, which are more common among women, unlike hyperplastic
polyps. Sessile serrated polyps are present in 2% to 9% of endoscopically rejected polyps and
7% to 21% of all nondysplastic serrated polyps (Higuchi & Jass, 2004; Torlakovic, Skovlund,
Snover, Torlakovic, & Nesland, 2003). The crypts of these polyps are dilated at their bases,
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frequently with branching or budding above the muscularis mucosae (Torlakovic et al., 2003;
Torlakovic & Snover, 1996).

Conventional adenomas.

This type of lesion is present in 40% to 60 % of removed colorectal polyps. The number
and size of the polyps are associated with the risk of cancer development (Winawer SJ, 1993).
Adenomas can be defined as red, multilobulated masses that are either plaque-like or
pedunculated (O’brien et al., 2004).
According to their morphological appearances, adenomas are classified into three
categories: tubular, villous, and tubulovillous. Tubular adenomas have at least a 75% volume of
tubular or branched crypts, while villous adenomas have at least a 75% volume of slender fronds
of a neoplastic epithelium. Lastly, tubulovillous adenomas only have a 25% to 75% volume
limited to villous polyps (Winawer SJ, 1993). By definition, all adenomas are considered
dysplastic and, depending on some cytologic and architectural features, the degree of dysplasia is
classified as low-grade dysplasia and high-grade dysplasia.
In low-grade dysplasia, crypts that are prominent infoldings of the epithelium narrower at
their bases compared to the surface have a variable size and are not oriented towards the
muscularis mucosae. The nuclei of cells maintain their position at the base of the cell and nuclei
are elongated with small nucleoli. Apoptotic cells are likely to be detected in the deep or
superficial positions of the crypts. A rich neutrophils infiltrate may also be present. On the other
hand, in high-grade dysplasia, crypts have a cribriform growth and irregular budding. The cells
in this type of crypt are stratified, with prominent nucleoli, mitotic figures, and luminal necrosis
(Fenoglio, Kaye, & Lane, 1973).
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The majority of colorectal adenocarcinomas develop via the adenoma-carcinoma
sequence. This is initiated by the adenomatous polyposis coli (APC) mutation, failing to
participate in the complex that sequesters and facilitates -catenin cytoplasmic degradation.
Then, APC--catenin/Wnt signaling allows cytoplasmic accumulation of -catenin, which is
then translocated to the nucleus facilitating transcription of protooncogenes and driving cell
proliferation. 80% of adenomas have an APC inactivating mutation, which nearly all show
aberrant nuclear -catenin immunoexpression, indicating that abnormalities in the Wnt signaling
pathway are universal in this type of lesion.

Serrated adenomas.

This type of polyp is uncommon, accounting for about 1% to 2% of endoscopically
removed colorectal adenomas (Longacre & Fenoglio-Preiser, 1990). Serrated adenomas have
tubules and villous projections of the lamina propria that support crypts with convoluted
architecture. Non-goblet epithelial cells are the most affected: the nuclei are elongated or
penicillate with small nucleoli and smooth contours (Yantiss, Oh, Chen, Redston, & Odze,
2007). Abnormalities in the APC/β-catenin/Wnt signaling are found in 13% to 20% of serrated
adenomas and up to 70% of serrated adenomas host KRAS- Mutations (O'Brien et al., 2006;
Sawyer et al., 2002).

Sessile serrated polyps with dysplasia.

This type of lesion is rare, accounting for 1% of all endoscopically removed polyps, and
is more frequent in women than men aged 50 or older. The pathological features are
heterogeneous, representing an intermediate stage in the progression of sessile serrated polyps to
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invasive carcinoma (via DNA methylation and MSI). KRAS mutations are identified in less than
10% of mixed polyps, while BRAF mutations are identified in 40% to 89% (Chan, Zhao, Leung,
& Yuen, 2003; Gala & Chung, 2011).
Risk Factors of Colon Cancer
Nonmodifiable risk factors.

Family history.
Roughly 10% of colorectal cancer cases are hereditary. They are caused by inherited gene
mutations and can be grouped in two main categories: Hereditary Nonpolyposis Colorectal
Cancer (HNPCC) and Familial Adenomatous Polyposis (FAP). HNPCC is caused by changes in
DNA repair genes; for example, a mutation in one of the DNA repair enzyme genes like MLH1,
MSH2, MLH3, MSH6, PMS1, or PMS2 (Kinzler & Vogelstein, 1996). The lifetime risk of
colorectal cancer in people with HNPCC may be as high as 80%. A large portion of FAP is
caused by a mutation in the APC gene (Feldman, Friedman, & Brandt, 2010). All individuals
diagnosed with FAP will develop colon cancer if the colon has not been removed by the age of
40. Having a first-degree relative affected by colorectal cancer is another factor that can increase
by two- to three-fold the risk of sporadic cancer. This risk can be even higher if the relative was
younger than 45 years old when diagnosed or if more than one first-degree relative was
diagnosed. A family history of adenomatous polyps also increases the risk of colorectal cancer
(American Cancer Society, 2017; Haggar & Boushey, 2009).
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Personal history.
Personal history plays an important role in colorectal cancer risk. Adenomatous polyps
are precursor lesions of colorectal cancer and it has been reported that around 95% of sporadic
colorectal cancer develops from these lesions (American Cancer Society, 2017). The risk of
developing colorectal cancer is higher in individuals with a history of adenomatous polyps than
in individuals with no personal history. Similarly, a personal history of inflammatory bowel
disease represents a relative risk of colorectal cancer between 4- to 20-fold (Feldman et al., 2010;
Haggar & Boushey, 2009).

Age.
The American Cancer Society recognizes an increase in the detection of colorectal cancer
after the age of 40, which rapidly increases after the age of 50. Nonetheless, recent studies have
reported an increasing incidence among younger people (O'Connell, Maggard, Livingston, &
Cifford, 2004).
Modifiable risk factors.

Body weight and physical activity.
Excess body weight and physical inactivity are two interrelated risk factors that are
responsible for about one-fourth to a third of colorectal cancers (Haggar & Boushey, 2009).
Obesity can be responsible for the lack of physical activity in daily routines in men and women
(Campbell et al., 2007; De Jong et al., 2005). On the other hand, higher overall levels of physical
activity are associated with a lower risk of colorectal cancer. The increase of circulating
estrogens and decrease of insulin sensitivity are some biological correlations of obesity that are
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believed to increase cancer risk, particularly associated with excess abdominal adiposity
independent of overall body adiposity. The increased risk of colorectal cancer associated with
body weight and physical activity may not only be due to an increased energy intake but may
reflect differences in metabolic efficiency (De Jong et al., 2005).

Alcohol.
An increased risk of developing colorectal cancer may be associated with regular alcohol
consumption (Zisman, Nickolov, Brand, Gorchow, & Roy, 2006). Some of the mechanisms
associated with alcohol consumption and cancer are: the production of acetaldehyde, as the first
metabolite of ethanol oxidation (which can function as a carcinogen), the induction of
cytochrome P-450E1 that leads to the generation of reactive oxygen species, and promotes the
activation of various procarcinogens. Alcohol may also function as a solvent and enhance
penetration of other carcinogens. In the presence of alcohol, some DNA mutations caused by
smoking are less efficiently repaired (Pöschl & Seitz, 2004). Moreover, a diet low in essential
nutrients is common in high alcohol consumers which can make tissues susceptible to
carcinogenesis (Marmot et al., 2007).

Cigarette smoking.
Smoking is responsible for about 12% of colorectal cancer deaths (Zisman et al., 2006).
Evidence has shown that smoking is an important factor in the formation and growth rate of
adenomatous polyps which are documented precursor lesions of colorectal cancer (Botteri,
Iodice, Raimondi, Maisonneuve, & Lowenfels, 2008). Long-term smoking has also been
associated with larger polyps found in the colon and rectum (Tsong et al., 2007; Zisman et al.,
2006). Alkaloids, phenolic compounds, volatile aldehydes, polycyclic aromatic hydrocarbons,
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tobacco specific nitrosamines and heavy metals, are classes of cigarette compounds that are
known to induce free radicals and possess toxic and carcinogenic activities (Zhang et al., 2012).
These compounds could induce tumorigenesis and promote cancer development in various
sections of the gastrointestinal tract through different mechanisms including, activation of
nicotinic acetylcholine receptors, the formation of DNA adducts, the stimulation of tumor
angiogenesis, and modulation of immune response (Li et al., 2014).

Environmental risk factors.
Cultural, social, and lifestyle factors are among the broadly defined “environmental
factors.” Migration and urban residence have been reported to increase the risk of colorectal
cancer. For example, the offspring of Japanese migrants to the United States have a three to four
times higher incidence of colorectal cancer than the Japanese living in Japan (Boyle & Langman,
2000). Diets are part of the environmental factor, and the main focus of our research.

Diet.
Some diets are associated with a higher incidence of colorectal cancer. These diets
include a high consumption of red or processed meat, a high consumption of fat, and a low
consumption of calcium, fiber, fruit, and vegetables (Haggar & Boushey, 2009). The positive
association of meat consumption is stronger for colon cancer than rectal cancer (Larsson &
Wolk, 2006). Animal fat is the main fat source associated with colorectal cancer, while fiber
intake may be responsible for the geographical differences in colorectal cancer rates observed
between Africa and Westernized countries (World Cance Research Fund International; Fund &
Research, 2007; Haggar & Boushey, 2009; 2017; Larsson & Wolk, 2006).
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Inflammation and Colon Cancer
Inflammation is a mechanism of the immune system as the first response to infection. In
the context of tissue injury, inflammation could be defined as: “a multifactorial network of
chemical signals to initiate and maintain a host response designed to heal the afflicted tissue.”
The main components of inflammation are cells (neutrophils, eosinophils, monocytes,
macrophages) and chemokines (Coussens & Werb, 2002).
Role of inflammation in colon cancer risk.
The relationship between inflammation and cancer is well accepted. This relationship has
been studied for centuries. One can refer to Virchow in 1863, who associated inflammation with
cancer (Fran Balkwill & Mantovani, 2001). In his hypothesis, he defined cancer as solely cell
proliferation, caused by some irritants, tissue injury, and the inflammatory response that
accompanied the injury. With the evolution of genetic technologies, many cancer pathways have
been discovered, demonstrating that cancer is not only a matter of cell proliferation but includes
a series of factors such as growth factors, an environment rich in inflammatory cells, active
stroma, and DNA- damage promoting agents (Coussens & Werb, 2002).
The relationship between colon inflammation and the development of colorectal cancer
has been studied in different types of colorectal cancer including sporadic and hereditary cancer.
Colitis-Associated cancer (CAC) is a subtype of colorectal cancer that might be most relevant to
this relationship and is associated with inflammatory bowel disease (IBD). Moreover, the
molecular mechanism by which inflammation promotes cancer development can vary from CAC
and other types of colorectal cancer. This mechanism can also vary depending on which step of
colon tumorigenesis inflammation is taking place, and it can include tumor initiation, promotion,
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progression, and metastasis (Terzić, Grivennikov, Karin, & Karin, 2010). Furthermore, chronic
inflammation is responsible for oxidative damages to DNA, which lead to p53 mutations in
inflamed epithelium and in tumor cells (Kraus & Arber, 2009). The mutations induced by
inflammation can be a result of the direct oxidation of reactive oxygen species and the
inactivation of mismatch repair enzymes at protein level (Colotta, Allavena, Sica, Garlanda, &
Mantovani, 2009; Hussain, Hofseth, & Harris, 2003). Additionally, mouse and human studies
have shown that DNA methyl transferases (Dnmt) 1 and 3 can be induced during inflammation
silencing several target genes in colon cancer, but the inactivation of Dnmt resulted in the
decrease of progression and suppression of tumor formation (Colotta et al., 2009; Hahn et al.,
2008).

The immune system in colon cancer.
Both CRC and CAC tumors are formed by different types of immune cells. Cells of the
innate immune system that can be detected in these tumors include: neutrophils, mast cells,
natural killer cells, dendritic cells (DCs) and tumor-associated macrophages (Atreya, Atreya, &
Neurath, 2008). In advance tumors, a specific subset of cells can be detected, named myeloidderived suppressor cells, which help suppressing antitumor immune responses (Gabrilovich &
Nagaraj, 2009). Cells from the adaptive immune system are also recruited and they may have
pro- or anti-tumorigenic roles (Erdman et al., 2005).

Cytokine Signaling and Tumor Promotion.
The majority of tumor-promoting cytokines activate receptors on intestinal epithelial cells
which activate oncogenic transcription factors and other oncogenic signaling pathways. Tumor
Necrosis Factor (TNF), IL-6, and IL-1 are cytokines that promote colorectal cancer and CAC
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tumor development. In contrast, IL-10 and TGF-β are cytokines that inhibit colorectal
tumorigenesis (Christoph Becker et al., 2004; S. Wang, Liu, Wang, & Zhang, 2009). Frequently,
in early states of CAC development tumor-promoting cytokines are produced by lamina propria
macrophages and DC and by T cells in a late stage of progression (Christoph Becker et al., 2004;
Grivennikov et al., 2009).
The activated protease ADAM17 mediates shedding of the membrane-bound IL-6
receptor. IL-6 receptor in its soluble form activates transcription factor STAT3 via transsignaling. IL-6 stimulates proliferation of premalignant enterocytes and tumor growth (C Becker
et al., 2005; Christoph Becker et al., 2004). STAT3 can also be activated by different cytokines
(IL-11, IL-22), growth factors (hepatocyte growth factor), epithelial growth factor receptor
ligands (TGF-α, EGF), and oncogenic tyrosine kinases (c-Met, Src) (Pickert et al., 2009). Once
activated, STAT3 protects the gastrointestinal epithelium and stimulates its regeneration,
promoting proliferation of pre-malignant cells (Grivennikov et al., 2009). The activation of
STAT3 produces the expression of Bcl2 or Bcl-xL (which are antiapoptotic genes), Cyclin D1 or
c-Myc (which are proliferative genes), and vascular endothelial growth factor (VEGF) (Naugler
& Karin, 2008a). The activation of STAT3 also induces prolonged activation of the transcription
factor NF-κB and both transcription factors activate genes required for every aspect of cancer
development (Lee et al., 2009). IL-6 promotes Th17 cell differentiation and regulates the
survival of proinflammatory Th1 cells while inhibiting T regulatory (Treg) cells (Bettelli et al.,
2006; Dominitzki et al., 2007).
TNF is produced during initial inflammatory response. Some of its properties include
production of other cytokines, chemokines and endothelial adhesion molecules, increase of
vascular permeability, and recruitment of activated leukocytes. As a result, TNF can be
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considered a tumor-promoting factor because it promotes inflammation angiogenesis and tumor
dissemination (Frances Balkwill, 2009). TNF also activates transcription factors AP-1 and NFκB (Frances Balkwill, 2009; Kruglov et al., 2008). Moreover, TNF is the main factor responsible
for inactivation of transcription factor T-bet in DCs that led to spontaneous intestinal
inflammation and CAC (Garrett et al., 2009).
Cytokines, that are upregulated in various types of cancers include IL-1 and IL-23. The
mechanisms of action of IL-23 in CRC and CAC are not clear but it could be due to the effect of
IL-23 on differentiation and propagation of Th17 cells or its effects in monocytes, memory T
cells, and Tregs (Garlanda et al., 2007; Wirtz & Neurath, 2007).
TGF-β has a contradictory role in cancer development. It displays an antitumorigenic role
by inhibiting proliferation, stimulating apoptosis, and by suppressing pro-tumorigenic cytokine
expression (LI Yang & Moses, 2008). However, during malignant progression, TGF-β promotes
epithelial-mesenchymal transition and suppresses the antitumor activity of immune cells to
facilitate metastasis (Bierie & Moses, 2010; Linda Yang, Belaguli, & Berger, 2009).
Proposed Inflammatory pathways.
NF-κB pathway
NF-κB transcription factors are dimers assembled through five subunits: p105/p50,
p100/p52, RelA (p65), c-Rel, and RelB. Active NF-κB signaling in premalignant and
inflammatory cells are responsible for the activation of the majority of tumor-promoting
cytokines (Karin, 2006). NF-κB activation can increase cell proliferation and angiogenesis,
inhibit cell death, and promote cell invasion and metastasis, all of which supports tumorigenesis
(Naugler & Karin, 2008b). Furthermore, the five subunits of NF-κB can be held inactive as

17
precursors in the cytoplasm or by the inhibitor of κB, Ikb protein. A simple explanation of the
activation of NF-κB via the classical route would be: 1) pattern recognition receptors, TNF, IL1,
and IL17 are the initial signal transduction pathways; 2) The initial signals activate the IKB
kinase (IKK) complex (mostly IKK GAMMA and BETA), which phosphorylates the IKBs; 3)
IKBs are targeted for ubiquitination and ultimate degradation in proteasome; and 4) after IKBs
degradation, NF-κB is liberated, mainly p50/p65, to migrate to nucleus and regulate gene
transcription (Vallabhapurapu & Karin, 2009). Another route to activate NF-κB is activation by
cytokines such as RANKL and lymphotoxin-B that would activate IKK alpha homodimer which
liberates mainly p52/ReIB NF-κB (Karin, 2006). In mouse studies, conditional ablation of IKKB
in enterocytes decreased tumor formation by 80% but did not affect tumor size, suggesting that
the activation of NF-κB is part of an early stage of tumor promotion rather than progression or
growth (Greten et al., 2004).

Wnt/β-catenin pathway
The Wnt/β catenin pathway plays a central role in the development of colorectal cancer.
Several molecules are involved in the positive or negative regulation of this pathway, with βcatenin being the most important and critical molecule among these.
In unstimulated cells free cytoplasmatic β-catenin is destabilized by a multiprotein
complex formed by Axin, glycogen synthase kinase 3β (GSK3) and APC (a tumor suppressor).
Interaction between Axin and GSK3 facilitates efficient phosphorylation of β-catenin by GSK3
and this phosphorylation event marks β-catenin for ubiquitination and ultimate destruction. On
the other hand, the cytoplasmatic protein Dishevelled (Dsh) is recruited to the membrane when
cells are stimulated by Wnt ligands. Dsh binds to Wnt through Frizzled (a transmembrane
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receptor for the Wnt ligands), the Wnt signaling prompts the inhibition of the destabilization of
free cytoplasmic β-catenin by the Axin complex. Now the stabilized β-catenin is release from the
Axin complex and is translocated into the nucleus where it binds to T cell factor (TCF) to
stimulate the transcription of Wnt target genes (Bienz & Clevers, 2000).
Additionally, APC is a protein normally expressed in nonproliferating colorectal
epithelium and is essential for the control of normal growth and cell differentiation
(MPOCC,2013). About 85% of all sporadic and hereditary colorectal tumors show loss of APC
function. Colon cancer cells with mutant APC contain high levels of free β-catenin which can be
down regulated by exogenous wild type APC. The anti-tumorigenic effects of APC are not only
limited to β-catenin degradation but also to the suppression of Wnt pathway by acting on
promoter of Wnt responsive genes and the shuttling of β-catenin out of the nucleus (MPOCC,
2013).

MAPK pathway
The mitogen activated protein kinase (MAPK) pathway is part of the family of serinethreonine kinases and it has three major subfamilies for MAPK: the extracellular signal-regulated
kinases (ERK MAPK, Ras/ Raf1/ MEK/ ERK), and the c-Jun N-terminal or stress-activated
protein kinase (JNK or SAPK; and MAPK14). It is well established that in humans beings these
three subfamilies can alter gene expression (Hommes, Peppelenbosch, & Van Deventer, 2003),
but ERK MAPK is the most relevant subfamily, as there is evidence that this pathway is
involved in the pathogenesis, progression, and oncogenic behavior of human colorectal cancer
(X. Wang, Wang, Hu, & Evers, 2004). In general, protein kinase C (PKC) activity promotes the
binding of GTP to the RAS family, which leads to Raf1 activation and subsequent MAPK
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activation. Furthermore, there is plenty of evidence that the inhibition of this pathway can
prevent tumor growth and therefore the pathway is potentially useful as targets for treatment of
colorectal cancer (Fang & Richardson, 2005; Sebolt-Leopold et al., 1999).
Diet and Colon Inflammation as a Risk of Colon Cancer
Diet constituents that increase colon cancer risk
Epidemiological studies have shown geographic variations in the incidence of colorectal
cancer. The disease is most frequent in developed countries with a western culture, accounting
for over 63% of all colorectal cancer cases (Haggar & Boushey, 2009). Among these studies, the
“migrant studies” have significant importance because they provide direct evidence that suggests
that environmental factors play a major part in the etiology of colorectal cancer. Around 70 to
80% of colorectal cancers may owe their appearance to such factors (Boyle & Langman, 2000).
In this type of study, populations migrating to a new and distant country and their offspring are
monitored. The results indicate that the groups of migrants lose the risk associated with their
country of origin to attain the patterns of their host country even after only one or two
generations. The environmental factor related to colorectal cancer can be defined as the wide illdefined cultural, social and lifestyles practices or in a general sense to everything we get in touch
with and we introduce into our organism (i.e., foods) (Boyle & Langman, 2000; Haggar &
Boushey, 2009; Mutanen & Pajari, 2011).
The influence of diet in colon cancer can go in two ways; diets that reduce the risk of
developing colon cancer and diets that contribute to the risk of developing colon cancer. In
respect to the diets that contribute to the risk of colon cancer a Western-style diet is positively
associated with the development of colorectal cancer. This diet is characterized by being high in
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meat, refined grains, and sugars while low in vegetables, and fiber (Slattery, 2000). Individual
food parameters such as fat and red and processed meat have also been associated with the risk
of colorectal cancer in ecological studies, animal experiments, and case-control and cohort
studies (Boyle & Langman, 2000; Haggar & Boushey, 2009).
The concept of a typical western diet is linked with the implication of fat, especially
animal fat, as a possible etiologic factor for colorectal cancer. It is believed that fats will favor
the development of bacterial flora capable of degrading bile salts to N-nitroso compounds that
have a carcinogenic potential (Haggar & Boushey, 2009; Larsson & Wolk, 2006; Santarelli et al.,
2008). The examination of saturated fat was modestly associated with elevated C-reactive
protein in 4,900 adult participants of the NHANES 99-00 (King, Egan, & Geesey, 2003). A
study carried out in TLR4-deficient and wild type mice, compared a low fat diet (10 % kcal fat)
to a high fat diet (60 % kcal fat) and found increased proinflammatory cytokines, increased
plasma and fecal endotoxin levels, dysregulation of gut microbiota, and induced colitis in
association with the high-fat diet (K.-A. Kim, Gu, Lee, Joh, & Kim, 2012).
Many studies have demonstrated the positive association of high consumption of red and
processed meat with the development of colorectal cancer. Santarelli et al, reviewed different
types of studies (cohort, case-control, and meta-analysis) in animals and in humans to gather
evidence and to explain possible mechanisms for the development of colorectal cancer. They
hypothesized that the potential mechanisms of this association are: the presence of heme iron in
red meat and the production of heterocyclic amines and polycyclic aromatic hydrocarbons from
meats cooked at high temperatures. They also found that processed meat has an excess risk of 20
to 50% in the highest category of processed meat-eaters compared to non-eaters. When
comparing dose-response per gram of processed meat with grams of red meat in meta-analysis
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studies, one gram of processed meat is at least twice and up to eleven times more promoting of
colorectal cancer than red meat (Haggar & Boushey, 2009; Larsson & Wolk, 2006; Santarelli et
al., 2008).
Furthermore, these studies only reflect the effect of individual foods but not the effect of
whole diets as would be consumed in everyday life. Therefore Shivappa et al. studied the
association between the inflammatory potential of overall diet and mortality with a focus on
cancer, specifically digestive-tract cancer mortality, including colorectal cancer. The diet
inflammatory index (DII) was previously developed with various inflammatory markers
including C-reactive protein, IL-1β, IL-4, IL-6, IL-10, and TNF-α. The study estimated that
subjects in a higher DII tertile were a 110% more likely to die from digestive-tract cancer than
those subjects in a lower DII tertile 1. It is also relevant that this study found an increased intake
of red meat in the lowest DII which is opposite to what was expected, but as this study took into
account diet as a whole, read meat eaters could have a lower DII if they ate sufficient amounts of
other anti-inflammatory components such as (fibers, vegetables, fruits) (Shivappa, Steck,
Hussey, Ma, & Hebert, 2017).
Diet constituents that decrease colon cancer risk
There is growing evidence that groups of vegetables, such as cruciferous and apiaceous,
may be beneficial in the prevention of colorectal cancer. A meta-analysis study evaluated 24
case-control studies and found an inverse association between high intake of cruciferous
vegetables and colorectal cancer risk with similar results with cabbage and broccoli (Wu et al.,
2013). Furthermore, there is also evidence of decreased inflammatory cytokines levels associated
with the consumption of cruciferous vegetables, for example: a multiethnic study found an
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inverse relationship between a vegetable dietary pattern (cruciferous and apiaceous vegetables
included) and the levels of CRP and IL-6 (Nettleton et al., 2006) Similarly, a randomized trial in
healthy adults used cruciferous vegetables and a combination of cruciferous plus apiaceous
vegetables, and concluded that both classes of vegetables were responsible for reduced levels of
IL-6 (Navarro et al., 2014). Moreover, Chinese middle-aged women had levels of TNF, IL1β,
and IL-6 inversely correlated with highest intake of cruciferous vegetables (Jiang et al., 2014).
Therefore, in the present project, we hypothesize that TWD would be as proinflammatory as DIO, and therefore a better dietary model of inflammation that reflects the
human conditions. Furthermore, we also expect that vegetable supplementation will reduce the
inflammatory response produced by diet, through the modulation of keys signaling pathways
such as: NF-κB pathway, Wnt/β catenin, or the MAPK.
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Chapter 3: Materials and Methods
Animals and experimental design
An animal use protocol was submitted and approved by the University of Arkansas
Institutional Animal Care & Use Committee (IACUC) to purchase a total of 84 male C57BL/6J
mice (~4 weeks old) from Jackson Laboratory (two sets of 42 mice two weeks apart from each
other).
Upon arrival, animals were housed at the Central Laboratory Animal Facility and adapted
to a vegetable free-chow diet for 1 week. On day 8 mice were randomly assigned to one of the 7
different diets (n=6) for a total of 12 weeks. Mice were housed in the following conditions: 7
cages of 16.75” x 10.5” x 6”, 6 mice per cage, temperature of 22±0.5ºC, 50% humidity, 12 hour
light/dark cycle, free access to water and diets, and bedding and water refreshment every 3 days.
Body weight and 24-hour food intake was measured once a week. The second set of mice was
handled with the same protocol. During the study, four mice from the TWD group were
euthanized; three due to skin problems related to one aggressive mouse in the cage and one with
a broken leg.
At the end of their assigned diet intervention, mice were euthanized with CO2 and by
cardiac puncture. Blood samples were collected with EDTA anticoagulant, livers were split in
two (one half preserved in liquid nitrogen and the other half in RNAlater solution), and colons
were washed with PBS and stored in RNAlater solution (life technologies, Carlsbad, CA).
Tissues stored in RNAlater solution were left overnight at 4 C and moved to -80 C after 24
hours.
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Study diets
Seven different types of diets were prepared for this study: AIN-93G (American Institute
of Nutrition, 1993 diet for growth, pregnancy and lactation) was used as control diet, DIO (dietinduced obesity), D+C (diet induced obesity plus 21% cruciferous vegetables), D+A (diet
induced obesity plus 21% apiaceous vegetables), TWD (total western diet), T+C (total western
diet plus 21% cruciferous vegetables), and T+A (total western diet and 21% apiaceous
vegetables). All diet ingredients were purchased from Dyets.inc (Bethlehem, PA). Powdered
ingredients were stored at -20C, while liquid ingredients were stored at 4C until needed. The
formulation of AIN-93G was based on Reeves, Nielsen, and Fahey’s work (1993). The DIO was
formulated to be a high fat diet (60% calories from fat) and TWD was also formulated based on a
previous work (Hintze, Benninghoff, & Ward, 2012). Cruciferous vegetable-supplemented diets
contained fresh watercress, broccoli, and green cabbage (21%, wet wt:wt; 7% per each
vegetable). Apiaceous vegetable-supplemented diets included fresh celery and parsnip (21%, wet
wt:wt; 10.5% per each vegetable). Furthermore, all vegetable supplemented diets were balanced
for macronutrients and dry weights for each vegetable was taken from the United States
Department of Agricultural nutrient database and summed according to each diet. Composition
of the study diets are summarized in Table 1.
Organically grown vegetables were purchased in three batches from two local markets:
broccoli, green cabbage, celery and parsnip at Ozark Natural Foods (Fayetteville, AR) and
watercress at Whole Foods (Fayetteville, AR). Diets were prepared the same day of purchase.
Vegetables were washed, dried with paper towels and peeled if necessary (parsnip), chopped into
small pieces, and ground in a food processor (Cuisinart Deluxe, NJ) to further be mix with either
DIO or TWD respectively using a mechanical mixer (Hobart, A-200-D) for 15 minutes.
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Each diet was aliquoted in freezer bags (1 bag = 1 week of feeding) and stored at -80C
until fed. Aliquots were thawed at room temperature and fed to animals every three to four days.
Plasma cytokine expression assay
After collection, blood samples were kept on ice, and centrifuged at 11,180g for 15
minutes at 4°C, supernatant (plasma) was collected and stored at -80°C on the same day of
sample collection. Before conducting the cytokine array, we determined the total protein
concentration using the 23227 PierceTM BCA protein assay kit from Thermo Fisher Scientific
(Waltham, MA), and we diluted the samples to the lowest protein concentration to perform the
array.
The ARY006 mouse cytokine array panel A (R&D Systems, Minneapolis, MN) was used
to assess systemic effects of the dietary intervention on plasma cytokine expression. In brief,
samples from two mice were pooled to obtain three pooled samples per diet group. Three
replicas were performed, each containing one pooled sample per diet group. Nitrocellulose
membranes with 40 selected capture antibodies spotted in duplicate were blocked with 2 mL of
array buffer six for one hour on a rocking platform shaker. 100 µl of pooled plasma samples
were mixed with 500 µl of buffer four, 900 µl of buffer six and 15 µl of biotinylated detection
antibodies and incubated at room temperature for one hour. Buffer six was aspirated from
membranes and samples mixture was added to membranes for overnight incubation at 2-8 °C on
a rocking platform shaker. On the next day membranes were removed from the mixture and
washed twice with 20 ml of wash buffer for ten minutes on a rocking platform shaker. After
wash, the excess buffer was drained with paper towels and membranes were incubated 30
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minutes with 2 mL of streptavidin-horse radish peroxidase at room temperature on a rocking
platform shaker.
The washing procedure was repeated and the next steps were performed in a dark room:
membranes were placed in a plastic sheet protector and one mL of chemiluminescent reagent
mix was added to the membranes and incubated for one minute, the excess reagent was removed
with absorbent lab wipes and membranes were place in an autoradiography film cassette.
Membranes were exposed in duplicate to X-ray film for five and ten minutes. The light produced
at each spot was proportioned to the amount of cytokine bound.
The signal intensity of the blot membranes was measured using the recommended
manufacturer software HLImage++ (Western Vision Software, Salt Lake City, UT).
Measurements were normalized with negative control spots and AIN-93G control diet.
Colon cytokine expression array
Moreover, we explored which inflammation-related genes may be differentially
expressed by the experimental diets, we used the PAMM-011Z Inflammatory Cytokines and
Receptors RT2 Profiler PCR Array (Qiagen, Hilden, Germany). In brief, RNA from colon tissue
was extracted and purified using the 73404 RNeasy Plus Universal Kit (Qiagen, Hilden,
Germany). Quality of isolated RNA was monitored with the measured A260/280 ratio and RNA
Integrity Numbers (Agilent 2100 Bioanalyzer, Santa Clara, CA). The assay was carried out in
pooled RNA samples of equal amounts from two mice for a total of six mice and three samples
per diet group: in brief, extracted RNA was reverse transcripted to cDNA following the
manufactures instruction on the PCR array using the ABI StepOnePlus real time-PCR system
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(Applied Biosystems, Waltham, MA). Data was normalized to housekeeping genes and analyzed
based on ΔΔCT method.
Statistical analysis
The software SPSS 19.0 was used to perform data analyses. One-way analysis of
variance (ANOVA) was used to determine statistical differences between basal diets (DIO diet
vs TWD diet) and the effect of added vegetables (no vegetables vs vegetable added diets) for
inflammatory responses. Individual group differences were inspected by Tukey test with a cutoff p-value of 0.05.
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Table 1. Composition of basal diets (AIN-93G, DIO, TWD) and vegetable supplemented
diets
Ingredients (g/Kg)

AIN93G*
397.5
200
132

DIO*

D+C*

D+A*

TWD*

T+C*

T+A*

Cornstarch
------230
220.4
207.99
Casein
258.46 253.96 256.48
190
185.5
188
Dextrinized
161.54 151.93 139.53
70
70
70
cornstarch
Sucrose
100
88.91
88.91
88.91
261.4 261.4
261.4
Fiber (cellulose
50
64.62
60.72
57.79
30
26.1
23.17
bw200)
Potassium citrate H2O
--21.32
21.32
21.32
------Dicalcium phosphate
--16.80
16.80
16.80
------Calcium carbonate
--7.11
7.11
7.11
------L-cystine
3
3.88
3.88
3.88
2.85
2.85
2.85
Sodium chloride
--------4
4
4
Choline bitartrate
2.5
2.58
2.58
2.58
1.4
1.4
1.4
Mineral mix ain-93ga
35
12.92
12.92
12.92
------Mineral mix custom
--------35
35
35
twdb
Vitamin mix ain-93gc
10
12.92
12.92
12.92
------Vitamin mix custom
--0.00
0.00
0.00
10
10
10
d
twd
Lard
--316.62 316.22 316.123
------Custom Fat blende
--------165.35
165
164.856
Soybean oil
70
32.31
32.31
32.31
------tBHQ
--0.01
0.01
0.01
------Cruciferous
210
--210
--vegetablesf
Apiaceous
--210
--210
vegetablesg
Total (g)
1000
1000.00 1210.00 1210.00 1000
1210 1209.985
Carbohydrate (%) h
62.95
25.05
24.64
24.40
56.14 55.24
54.70
Protein (%) h
20.00
25.85
25.43
25.18
19.00 18.69
18.51
h
Fat (%)
7.00
34.89
34.33
34.00
16.54 16.27
16.11
Dietary fiber (%) h
5.00
6.46
6.36
6.30
3.00
2.95
2.92
*AIN-93G (American Institute of Nutrition, 1993 diet for growth, pregnancy and lactation), DIO
(diet-induced obesity), D+C (diet induced obesity plus 21% cruciferous vegetables), D+A (diet
induced obesity plus 21% apiaceous vegetables), TWD (total western diet), T+C (total western
diet plus 21% cruciferous vegetables), and T+A (total western diet and 21% apiaceous vegetables).
a
AIN-93G mineral mix, purchased from dyets.inc catalog #210025.bCustom TWD mineral mix,
purchased from dyets.inc catalog #210107. cAIN-93G vitamin mix purchased from dyets.inc
catalog #310025. dCustom TWD vitamin mix, purchased from dyets.inc catalog #310088. eCustom
fat blend for the University of Minnesota, purchased from dyets.in catalog #103860. fWatercress
(70g), broccoli (70g), and green cabbage (70g), macronutrients peer group: carbohydrate 9.61g,
protein 4.48g, fat 0.4g, fiber 3.90g. gCelery (105g) and parsnip (105g), macronutrients peer group:

29
carbohydrate 22.01g, protein q1.98g, fat 0.50g, fiber 6.80g. hPercent of macronutrient after
removing water weight of vegetables: 193.62g from cruciferous and 183.71g from apiaceous.
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Chapter 4: Results
Food intake
There were no differences in food intake between groups on week one of the study. On
week 6, mice in TWD (14.99 kcal ± 0.21), TC ( 14.22 kcal ± 0.52) and TA (14.35 kcal ± 0.65)
had decreased food intake compared to AIN-93G (20.17 kcal ± 2.88). At the end of the study
(week 12) mice in DIO group (26.79 kcal ± 5.15) had increased food intake compared to all
other groups except DC group.
Body and Tissue weight
Initial body weight of animals was between 21.64g to 28.56g. There were some
unexpected differences in weight gain between some diet groups. The DIO group did not differ
in weight gain compared to any other group (Figure 2). Weight gain of mice in DC (19.44g ±
1.62) group was higher than the weight gained by mice on TWD (11.17g ± 1.75) and AIN-93G
diet (11.41g ± 0.60), the latter having the lowest mean value. There were no differences in colon
and liver weight between diet groups (Table 2).
Plasma cytokine expression assay
The mouse cytokine array panel A is able to detect 40 types of cytokines. This is a
screening assay, therefore results are relative and not finite. In our study 18 cytokines (G-CSF, I309, IL-2, IL-5, IL-6, IL-7, IL-17, IL-23, IP-10, I-TAC, KC, M-CSF, MIP-2, SDF-1, TARC,
TIMP-1, TNF-α, and TREM-1) were differentially expressed between diet groups (Figure 3).
Mice in AIN-93G, DIO, and TWD had similar cytokine secretion profile with the lowest means
compared to the vegetable-supplemented diets. KC was the only cytokine that increased in DIO
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compared with TWD (p = 0.036). Cytokine signals in DC had the same secretion profile as
cytokines in DIO with lower means but no statistical difference, while some cytokine signals in
DA were likely to be increased when compared to DIO (G-CSF, IL-5, IL-6 , IL-7, I-TAC, TNFα, TREM-1; p < 0.015) and when compared to DC (G-CSF, IL-2, IL-5, IL-7, IL-23, IP-10, ITAC, M-CSF, TARC, TIMP-1, TNF-α; p < 0.026). Most cytokines in TC and TA had similar
secretion profiles as TWD with slightly higher means, and with only three cytokines (G-CSF, I309 and M-CSF; p < 0.005) in TA with increased secretion compared to TWD. Cytokine
secretion of IL-17 was increased on TC compared to DC; p = 0.042. MIP-2 expression was
higher on TWD compared to AIN-93G and DC; p = 0.019, while SDF-1 was decreased on all
diets compared to AIN-93G diet; p = 0.00.
Colon cytokine expression array
Only four inflammation-related genes were statistically different between diets. Bmp2
had a higher mRNA expression in all diets compared to basal diet AIN-93G (p= 0.001). Ccl1 had
similar mRNA expression in all diets compared to AIN-93G and DIO which had the lowest (p=
0.001). Ccl19 mRNA was equally expressed in all diets except for DIO which had a lower
expression (p< 0.001). Ccl4 had a higher mRNA expression in TC diet only when compared with
DIO and DC (p= 0.058).
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Table 2. Weight of colon and liver tissues collected from C57BL/J6 mice by diet group.
Diet*

Colon (g)

Liver (g)

AIN-93G

15.87 ± 1.02

169.91 ± 8.05

DIO

16.64 ± 0.88

172.46 ± 8.71

DC

17.13 ± 1.28

214.39 ± 29.54

DA

15.75 ± 0.94

182.07 ± 17.32

TWD

15.60 ± 0.93

164.68 ± 20.40

TC

13.32 ± 0.46

160.92 ± 6.61

TA

13.53 ± 1.17

170.43 ± 17.51

*AIN-93G (American Institute of Nutrition, 1993 diet for growth, pregnancy and lactation), DIO
(diet-induced obesity), D+C (diet induced obesity plus 21% cruciferous vegetables), D+A (diet
induced obesity plus 21% apiaceous vegetables), TWD (total western diet), T+C (total western
diet plus 21% cruciferous vegetables), and T+A (total western diet and 21% apiaceous
vegetables).Values are reported as least squares means ± SEM, n=6 per diet group.
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Figure 1. 24-hour food intake of C57BL/J6 mice by week. Food cups were weighed on day of
feeding (0 hour) and again 24 hours later. Cup weight at 0 hours was subtracted from cup weight
at 24 hours and then divided by total animals on respective diets. This was measured once a
week. AIN-93G (American Institute of Nutrition, 1993 diet for growth, pregnancy and lactation),
DIO (diet-induced obesity), D+C (diet induced obesity plus 21% cruciferous vegetables), D+A
(diet induced obesity plus 21% apiaceous vegetables), TWD (total western diet), T+C (total
western diet plus 21% cruciferous vegetables), and T+A (total western diet and 21% apiaceous
vegetables). Values are reported as least squares means ± SEM, n=6 per diet group. Values
within time points that do not share the same lowercase letters are different from each other
(P˂0.05). Food intake is expressed on dry weight basis as describe by Kim et al. 2017.
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Figure 2. Weight gain of C57BL/J6 mice by diet group. Weight gain was monitored once a
week. Initial weight (day 0) was subtracted from final weight (day 85). AIN-93G (American
Institute of Nutrition, 1993 diet for growth, pregnancy and lactation), DIO (diet-induced obesity),
D+C (diet induced obesity plus 21% cruciferous vegetables), D+A (diet induced obesity plus
21% apiaceous vegetables), TWD (total western diet), T+C (total western diet plus 21%
cruciferous vegetables), and T+A (total western diet and 21% apiaceous vegetables).Values are
reported as least squares means ± SEM, n=6 per diet group. Bars that do not share the same
lowercase letters are different from each other (P˂0.05).
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Figure 3. Effects of seven different diets on plasma cytokine secretion in C57BL/6J mice.
AIN-93G (American Institute of Nutrition, 1993 diet for growth, pregnancy and lactation), DIO
(diet-induced obesity), D+C (diet induced obesity plus 21% cruciferous vegetables), D+A (diet
induced obesity plus 21% apiaceous vegetables), TWD (total western diet), T+C (total western
diet plus 21% cruciferous vegetables), and T+A (total western diet and 21% apiaceous
vegetables). The relative level of each cytokine or chemokine was calculated using HLImage++
software (Western Vision Software, Salt Lake City, UT). Values are reported as least squares
means ± SEM, n=4 per diet group. Bars that do not share the same lowercases letters are
different from each other (P˂0.05).
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Figure 4. Effects of seven different diets on mRNA expression of inflammation-relate genes
in C57BL/6J mice. AIN-93G (American Institute of Nutrition, 1993 diet for growth, pregnancy
and lactation), DIO (diet induced obesity), D+C (diet induced obesity plus 21% cruciferous
vegetables), D+A (diet induced obesity plus 21% apiaceous vegetables), TWD (total western
diet), T+C (total western diet plus 21% cruciferous vegetables), and T+A (total western diet and
21% apiaceous vegetables). mRNA from colon tissue was extracted, purified and reverse
transcripted to cDNA following manufactures instruction, real time PCR was run with the RT2
profiler PCR array, data was normalized to housekeeping genes and analyzed based on ΔΔCT
method. Values are reported as least squares means ± SEM, n=6 per diet group. Bars that do not
share the same lowercase letters are different from each other (P˂0.05).
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Chapter 5: Discussion and Future Directions
Mice are one of the most useful models to study human diseases. Researchers are always
trying to mimic human conditions; in this manner, the AIN-93G diet has widely been used to
replicate an ideal human diet in mice models, and DIO to reproduce obesity, but none of these
diets represent the larger group of Americans with an average diet. In an effort to replicate the
average American diet, scientists developed the TWD as a background diet for rodent studies.
TWD has not been compared to DIO regarding effects on colon inflammation. This is why in our
study we wanted to compare these two diets in order to determine whether TWD is as proinflammatory as DIO and a better model for human diseases, especially colon cancer, as it is a
model more translatable to human conditions. Moreover, previous studies have demonstrated the
chemo-preventive potential of cruciferous and apiaceous vegetables in the prevention of colon
cancer (Koushik et al., 2007; Tse & Eslick, 2014; Wu et al., 2013), and colon inflammation is
one of the conditions closely related with colon cancer initiation. Therefore, we also wanted to
investigate the effect of these two classes of vegetables on colon inflammation. In the following
pages, we discuss our findings, the strengths and limitations of our study, and what would be the
further direction of our research.
In our study, the similar plasma cytokine secretion profile found in AIN-93G compared
to DIO, and TWD, differs from the study of Kyung-Ah Kim et al., where a high-fat diet (60%
kcal % fat) produced higher levels of proinflammatory cytokines (TNF-α, IL-1β, and IL-6)
compared to a low-fat diet (10% kcal % fat) (2012), using the same animal model C57BL/6J as
our study. In their study they also report an increased body weight of mice in the high-fat diet
group compared to mice in low-fat diet group, which differs from our study where body weight
gain of mice in DIO (high-fat diet) did not differ from any other diet, meaning DIO did not have
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the effect we expected (i.e., the percent body weight gain in DIO statistically higher than AIN93G). Another study using the same mouse model and a western style diet in cardiac hypertrophy
reported increased body weight of mice in the western-style diet compared to the basal chow diet
group (Mells et al., 2011), which was not the case with our western-style diet (bodyweight gain
of mice on TWD was equal as the body weight gain of mice on AING-93G diet).
Even though we were not expecting a similar expression profile of any diet compared to the
basal diet AING-93G, we were expecting similarities in DIO and TWD (i.e. the same cytokines
increased or decreased at the same time in both diets).
To assess the systemic inflammatory response of mice to seven different diets, we
measured 40 different cytokines in plasma samples. The higher levels of plasma cytokine
secretion in all vegetable supplemented diets compared to the basal diets (AIN- 93G, DIO TWD)
also differs from the inverse relationship previous studies have found between vegetable
consumption and inflammatory markers (Jiang et al., 2014; Navarro et al., 2014; Nettleton et al.,
2006). Nonetheless, all these studies were carried out in humans.
Moreover, from the analysis of inflammation-related genes in colon samples, none of the
four colon differentially expressed genes found in our study (Bmp2, Cccl1, Cccl4, Cccl19) were
altered in the study of Liu et al. (2012) using colon ex vivo culture samples, where obese mice
had 11 genes up-regulated and 18 genes down-regulated using the same animal and gene array as
our study. However, they used older mice (6 to 18 weeks old) than our study (4 weeks old) and
they fed the high fat diet for 12 weeks in one cohort and 17 weeks in the other.
It is widely accepted that adipose tissue expresses higher levels of pro-inflammatory
cytokines (TNF- α, IL-1, IL-6) in diet-induced obesity models, and that the macrophages that
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infiltrate the tissue are responsible for the expression of TNF-α and, IL-6, and the induction of
nitric oxide synthase (Rajala & Scherer, 2003); several studies have reproduced these findings
(K.-A. Kim et al., 2012; Liu et al., 2012). From the review of their methodology and their results,
we have several discrepancies that may explain the failure of our study to induce obesity and
inflammation in mice with high-fat diet, and therefore the ability to determine if there is a
decrease in cytokine expression with vegetable-supplemented diets. Stanton et al. (2011) stated
that C57BL/6 mice do not gain weight uniformly when fed a high-fat diet, and they decided to
exclude from the study all mice with less than 7 gram weight gain on day 21 of high-fat diet
feeding. It is important to mention that in this study cytokine expression was measured in serum
samples and only IL-6 had a modest increased in the high-fat diet group, while GM-CSF, TNFα, IL-12p70, and IL-1β did not have any increase (levels below the detection limit of the assay).
Studies that did report elevated levels of TNF- α (K.-A. Kim et al., 2012; Liu et al., 2012), IL-1β,
IL6 (K.-A. Kim et al., 2012) assessed levels in colon tissue. Concerning the vegetablesupplemented diets with higher cytokine expression, DC diet had a lowering effect on
inflammation (with 11 decreased cytokines) compared to DA, which additionally had 7 other
cytokines increased compared to DIO. The increase in cytokines such as TNF- α, IL6, IL17, and
IL23, suggest the promotion of inflammation by the vegetable supplemented diets as these
cytokines are responsible for the activation of the NF-κB transcription factor through the
canonical pathway. Il-6 can also lead to the activation of STAT3 transcription factor, and induce
expression of anti-apoptotic genes (Bcl2) and proliferative genes (Cyclin D1, c-Myc), all together
promoting inflammation and angiogenesis, and inhibiting cellular apoptosis (Terzić et al., 2010).
We focused our research on the chemo-preventive effect of cruciferous and apiaceous
vegetables, nonetheless some studies have reported that some compounds (e.g. Indol-3-carbinol)
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present in these types of vegetables are responsible for the promotion of colon cancer (Pence,
Buddingh, & Yang, 1986; Temple & El-Khatib, 1987). Furthermore, a trial in healthy adults
showed a 19% and 20% reduction of IL-6 level by cruciferous- and apiaceous-supplemented
diets, but no effect of the vegetables on TNF-α or C-reactive protein as markers of inflammation
(Navarro et al., 2014). All of the above is evidence of the variable effects diet can have on
inflammation.
If we compare the plasma cytokine secretion of the ARY006 protein assay with the colon
mRNA qPCR assay, one can observe that I-309 (Ccl1) was the only gene with increased levels in
both assays. Nonetheless, protein secretion (I-309) was higher in TA compared to all basal diets
(AIN-93G, DIO, TWD), but mRNA secretion was higher in TWD, TC, and TA compared to
AIN-93G and DIO. This can be due to a post-transcriptional modification of the mRNA of the
elevated cytokines identified with the protein array. In general, differentially expressed mRNAs
are involved in the recruitment of cells of the immune system (neutrophils, monocytes, tumorinfiltrating lymphocytes) (Viola, Sarukhan, Bronte, & Molon, 2012), with lower levels on AIN93G, DIO, and DC diet.
One of the main strengths of our study is the formulation of the vegetable supplemented
diets DC and DA (TC, TA had been previously formulated by Kim et al. (2016)) for many
reasons: diets were prepared in our lab, all ingredients were purchased from the same company
and with the same lot number, we used a mix of whole vegetables (not purified phytochemicals)
in quantities equivalent to a translatable amount of one cup per day for a human, and diets were
adjusted for macronutrients so even with the supplementation of vegetables all diets had the
same proportion of macronutrients.
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The main limitation of our study was that mice on high-fat diets did not achieve obesity,
which made it difficult to compare our results of the vegetable supplemented diets (DC, DA, TC,
TA) to basal diets (AIN-93G, DIO, TWD). Another limitation is that we only measured the
cytokine levels at the end of the feeding period, so we did not have baseline measurements of the
cytokine levels to compare levels after the feeding trial. We had some difficulties measuring 24hour food intake of the powder diets (AIN-93G, TWD), due to spillage of the diet, which we
resolved somewhat with the use of followers (a special metal lid, with 6 small circular openings);
but we also believe that the small openings of our food shields and the weight gain of mice over
time may have cause some skin lesions, therefore we recommend using food cups with bigger
openings. Moreover, testing the cytokine expression on plasma samples was a challenge due to
the limited amount of sample per mouse, and the probability of protein degradation over time
and per time the sample was thawed.
Based on the results of our research, we recommend following certain parameters to
classify a mouse as obese and monitor their weight gain. Selection can be based on the
percentage of body weight compared to basal diet (30-35% above basal diet), limiting the
treatment (diet) to the time this parameter is achieved as was describe by Liu et al. (2012). They
used 17 weeks for one cohort and 12 for the other. Also, have enough replicas of mice per group
of diet so that once obesity is reached, some can be sampled at this time point and the others can
separate into groups of diet supplemented with cruciferous or apiaceous vegetables for the time
we consider that the vegetables would produce an anti-inflammatory and chemo-preventive
effect. As the adipose tissue plays an important role in pro-inflammatory cytokine secretion, the
measurement of total body fat could be a useful parameter to compare cytokine levels. If
possible, measure the cytokine expression in blood, adipose tissue, and colon epithelial cells, as
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cytokines can have a different expression pattern depending on the tissue type. Also, immunohistological testing could be used to confirm macrophage infiltration of tissues, which cells are
primarily responsible for por-inflammatory cytokine secretion.
We did not determine that DIO and TWD both induce inflammation and both diets failed
to induce obesity, nevertheless the cytokine expression profile of these diets was similar.
Therefore, we did not discard the possibility for a future study which could monitor and achieve
obesity by these diets and possibly still have a similar cytokine expression.
The stimulation of higher cytokine secretion by the vegetable-supplemented diets
compared to basal diets only reassures the complexity and variable effects of vegetables on
pathways in complex organisms.
Vegetable-supplemented diets did not have an anti-inflammatory effect but, on the
contrary, induced the secretion of some pro-inflammatory cytokines. Nonetheless, cruciferous
vegetables had a smaller response compared to apiaceous vegetables. This contradiction provides
evidence of the complexity and variability of diet (vegetable) effects on inflammation, and the
importance of studying their molecular mechanisms as seemingly negative effects on one type of
pathway should not lead to discarding evidence of its chemo-preventive effects via other
pathways.
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